Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Minocycline hydrochloride
Medication labelMinocycline hydrochloride extended-release tablets are indicated to treat inflammatory lesions of non-nodular moderate to severe acne…
Why this: Advisory · dailymed-prescription
Minocycline hydrochloride extended-release tablets are indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies (14)]. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated [see Warnings and Precautions (5.12)].
- generic_name
- minocycline hydrochloride
- product_names
- minocycline hydrochloride
- ndc
- 68382-531, 68382-531-06, 68382-531-16, 68382-531-01, 68382-531-05, 68382-531-10, 68382-531-30, 68382-550, 68382-550-06, 68382-550-16, 68382-550-01, 68382-550-05, 68382-550-10, 68382-550-30, 68382-532, 68382-532-06, 68382-532-16, 68382-532-01, 68382-532-05, 68382-532-10, 68382-532-30, 68382-551, 68382-551-06, 68382-551-16, 68382-551-01, 68382-551-05, 68382-551-10, 68382-551-30, 68382-533, 68382-533-06, 68382-533-16, 68382-533-01, 68382-533-05, 68382-533-10, 68382-533-30, 68382-552, 68382-552-06, 68382-552-16, 68382-552-01, 68382-552-05, 68382-552-10, 68382-552-30, 68382-534, 68382-534-06, 68382-534-16, 68382-534-01, 68382-534-05, 68382-534-10, 68382-534-30, 68382-535, 68382-535-06, 68382-535-16, 68382-535-01, 68382-535-05, 68382-535-10, 68382-535-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en